Guide highlights key compliance scenarios—from FDA actions to global expansion—where consulting is essential. IRVINE, ...
In its effort to play catch up after thousands of factory inspections were delayed during the coronavirus pandemic, the FDA is still lagging woefully behind and is unable to approach its pre-COVID ...
Foreign facilities failed FDA GMP inspections at up to 1.8x the U.S. rate. Journal of Pharmaceutical Innovation study quantifies a decade of oversight gaps. We first need rigorous, replicable ways to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results